文献速递关节外科

大麻合法化后接受全关节置换术患者自报大麻使用情况是否改变

Has Self-reported Marijuana Use Changed in Patients Undergoing Total Joint Arthroplasty After the Legalization of Marijuana?
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

该回顾性研究分析科罗拉多州大麻商业销售合法化前后各500例初次全关节置换术患者病历,自报大麻使用率从合法化前1%(4/500)升至合法化后11%(55/500)(OR 15.3,95%CI 5.5-42.6,p<0.001),使用与年轻、男性、吸烟、物质滥用史、仅Medicaid保险及术前麻醉药使用相关。作者结论认为现有证据不支持全关节置换术后使用大麻,需前瞻性随机研究进一步探讨。

要点

  • 大麻合法化后全关节置换患者自报使用率从1%升至11%,OR 15.3(95%CI 5.5-42.6,p<0.001)。
  • 使用者中46%为娱乐性、26%为药用、27%未报告原因、2%兼有娱乐与药用。
  • 使用相关因素包括年轻、男性、当前吸烟、物质滥用史、仅Medicaid保险及术前麻醉药使用。

核心结论

  • 作者认为大麻合法化导致使用者增多或更多患者愿意报告使用,因无法律后果。
  • 作者指出迄今证据不支持全关节置换术后使用大麻,需前瞻性随机研究关注阿片消耗、恶心、睡眠模式及结局后方可提出使用建议。

研究设计与样本

  • 回顾术前病史与体检以获取自报大麻使用及原因(药用或娱乐),并记录保险类型、年龄、性别、吸烟状态、物质滥用史、术前麻醉药使用、酒精摄入及关节置换类型。

主要发现

  • 合法化后自报使用率从1%(4/500)升至11%(55/500)(OR 15.3,95%CI 5.5-42.6,p<0.001)。
  • 合法化后使用者中46%(25/55)报告娱乐性使用,26%(14/55)药用,27%(15/55)未报告原因,2%(1/55)兼有娱乐与药用。
  • 使用者较非使用者更年轻(组间平均差10年,p<0.001)。
  • 男性使用者36/59(61%)vs 非使用者411/941(44%)(OR 2.02,p<0.01)。
  • 当前吸烟者使用者22/59(37%)vs 非使用者54/941(6%)(OR 0.09,p<0.01);物质滥用史使用者8/59(14%)vs 非使用者18/941(2%)(OR 8.04,p<0.001);仅Medicaid保险使用者28/59(48%)vs 非使用者56/941(6%)(OR 20.45,p<0.01);术前麻醉药使用使用者8/59(14%)vs 非使用者17/941(2%)(OR 2.4,p<0.001)。

关键数值与推荐

  • 合法化后自报大麻使用率11%(55/500)vs 合法化前1%(4/500)(OR 15.3,95%CI 5.5-42.6,p<0.001)。
  • 男性使用者36/59(61%)vs 非使用者411/941(44%)(OR 2.02,p<0.01)。
  • 当前吸烟使用者22/59(37%)vs 非使用者54/941(6%)(OR 0.09,p<0.01)。
  • 物质滥用史使用者8/59(14%)vs 非使用者18/941(2%)(OR 8.04,p<0.001)。
  • 仅Medicaid保险使用者28/59(48%)vs 非使用者56/941(6%)(OR 20.45,p<0.01);术前麻醉药使用使用者8/59(14%)vs 非使用者17/941(2%)(OR 2.4,p<0.001)。

临床怎么用

  • 作者结论指出迄今证据不支持全关节置换术后使用大麻,需前瞻性随机研究关注阿片消耗、恶心、睡眠模式及结局后方可提出使用建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Marijuana use has become more accessible since its recent legalization in several states. However, its use in a total joint arthroplasty population to our knowledge has not been reported, and the implications of its use in this setting remain unclear. QUESTIONS/PURPOSES: We report (1) the self-reported use of marijuana in patients undergoing total joint arthroplasty both before and after its legalization; and (2) clinical and demographic factors associated with marijuana use in patients undergoing total joint arthroplasty. METHODS: One thousand records of patients undergoing primary total joint arthroplasty (500 consecutive before and 500 consecutive after the legalization of the commercial sale of marijuana in Colorado) were included for analysis. Preoperative medical history and physicals were retrospectively reviewed for self-reported and reasons (medicinal versus recreational) for use. Additionally, patient records were used to determine insurance type, age, gender, smoking status, history of substance abuse, preoperative narcotic use, alcohol intake, and the type of arthroplasty performed. RESULTS: Self-reported use after legalization dramatically increased from 1% (four of 500) to 11% (55 of 500) (odds ratio [OR], 15.3 [95% confidence interval, 5.5-42.6]; p < 0.001) after legalization. For those reporting use after legalization, 46% (25 of 55) of patients reported recreational use, 26% (14 of 55) medicinal use, 27% (15 of 55) did not report a reason for use, and 2% (one of 55) reported both recreational and medicinal use. Factors associated with use included younger age (with a 10-year mean difference between the groups [p < 0.001]), male gender (36 of 59 users [61%] versus 411 of 941 nonusers [44%]; OR, 2.02; p < 0.01), current smokers (22 of 59 users [37%] versus 54 of 941 [6%] nonusers; OR, 0.09; p < 0.01), a history of substance abuse (eight of 59 users [14%] versus 18 of 941 nonusers [2%]; OR, 8.04; p < 0.001), insurance type (Medicaid only, 28 of 59 [48%] users versus 56 of 941 [6%] nonusers; OR, 20.45; p < 0.01), and preoperative narcotic use (eight of 59 users [14%] versus 17 of 941 nonusers [2%]; OR, 2.4; p < 0.001). We did not find differences with regard to alcohol use, amount of alcohol consumption, or insurance types other than Medicaid. CONCLUSIONS: These results suggest the legalization of marijuana has led to either more users or more patients who are willing to report its use given the lack of legal ramifications. Despite these findings, the evidence to date precludes the use of marijuana postoperatively in patients undergoing total joint arthroplasty. Further investigation, ideally in a prospective randomized manner, should focus on opioid consumption, nausea, sleep patterns, and outcomes in patients using marijuana who are undergoing total joint arthroplasty before recommendations can be made for its use. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Jennings JM, Williams MA, Levy DL, et al. Has Self-reported Marijuana Use Changed in Patients Undergoing Total Joint Arthroplasty After the Legalization of Marijuana? Clin Orthop Relat Res. 2019. PMID: 30794232. doi:10.1097/CORR.0000000000000339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。